Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380276 · ClinicalTrials.gov registry record · Phase 3
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
A Phase 3 study, sponsored by Myrexis.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
NCT00380276 is a Phase 3 study that was terminated before completion, run by Myrexis. The registered enrollment target is 1,000 participants.
The verdict
NCT00380276, a Phase 3 study, was terminated before completion, sponsored by Myrexis.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
Open-label treatment with MPC-7869 for participants in a previous randomized study.
Interventions
- DRUG MPC-7869
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00380276
The ClinicalTrials.gov registry entry for NCT00380276 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myrexis, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MPC-7869 is the first listed.
NCT00380276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00380276 about?
NCT00380276 is a clinical study titled "Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol". Open-label treatment with MPC-7869 for participants in a previous randomized study.
What is the current status of trial NCT00380276?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2006-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00380276?
The interventions under investigation include: MPC-7869 (DRUG).
Who is sponsoring clinical trial NCT00380276?
This trial is sponsored by Myrexis, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.